Macleods Pharmaceuticals Ltd — Moxifloxacin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Moxifloxacin · $1.4M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #1 Indian exporter of Moxifloxacin with $1.4M in export value and 27 verified shipments. Macleods Pharmaceuticals Ltd holds a 4.1% market share in Moxifloxacin exports across 14 countries.
Macleods Pharmaceuticals Ltd — Moxifloxacin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Moxifloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $200.0K | 4 | 17.9% |
| SOUTH AFRICA | $182.4K | 13 | 16.3% |
| PHILIPPINES | $150.0K | 3 | 13.4% |
| NETHERLANDS | $147.3K | 4 | 13.2% |
| UNITED STATES | $100.0K | 2 | 8.9% |
| YEMEN, DEMOCRATIC | $66.0K | 2 | 5.9% |
| UKRAINE | $50.0K | 1 | 4.5% |
| KAZAKHSTAN | $50.0K | 1 | 4.5% |
| KAZAKISTAN | $50.0K | 1 | 4.5% |
| YEMEN | $20.0K | 1 | 1.8% |
Macleods Pharmaceuticals Ltd exports Moxifloxacin to 19 countries. The largest destination is NIGERIA accounting for 17.9% of Macleods Pharmaceuticals Ltd's Moxifloxacin shipments, followed by SOUTH AFRICA (16.3%) and PHILIPPINES (13.4%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Moxifloxacin from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS SA | SOUTH AFRICA | $148.1K | 12 |
| CLINICAL RESEARCH PRODUCT | UNITED STATES | $100.0K | 2 |
| DEPARTMENT OF HEALTH - -PHILIPPINES | PHILIPPINES | $100.0K | 2 |
| NATIONAL TUBERCULOSIS AND LEPROSY CONTROL | NIGERIA | $100.0K | 2 |
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $100.0K | 2 |
| I SOLUTIONS | NETHERLANDS | $100.0K | 2 |
| INMA PHARMA FOR IMPORT AND | YEMEN, DEMOCRATIC | $85.9K | 3 |
| MACLEODS PHARMACEUTICAL LIMITED LLC | UKRAINE | $50.0K | 1 |
| BRANCH CO MACLEODS PHARMACEUTI CALS LTD | KAZAKHSTAN | $50.0K | 1 |
| BRANCH COMPANY MACLEODS PHARMACEUTI | KAZAKISTAN | $50.0K | 1 |
Macleods Pharmaceuticals Ltd supplies Moxifloxacin to 22 buyers globally. The largest buyer is MACLEODS PHARMACEUTICALS SA (SOUTH AFRICA), followed by CLINICAL RESEARCH PRODUCT (UNITED STATES) and DEPARTMENT OF HEALTH - -PHILIPPINES (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Moxifloxacin Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $14.3M worth of Moxifloxacin through 2,413 shipments from 336 suppliers to 137 countries, serving 731 buyers globally. Macleods Pharmaceuticals Ltd contributes $1.4M to this total, accounting for 4.1% of India's Moxifloxacin exports. Macleods Pharmaceuticals Ltd ships Moxifloxacin to 19 countries through 22 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Moxifloxacin Exports?
Macleods Pharmaceuticals Ltd's average Moxifloxacin shipment value is $50.0K per consignment, based on 27 shipments totaling $1.4M. The largest destination is NIGERIA (17.9% of Macleods Pharmaceuticals Ltd's Moxifloxacin exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Moxifloxacin Exporters?
Macleods Pharmaceuticals Ltd ranks #1 among 336 Indian Moxifloxacin exporters with a 4.1% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($2.3M), MICRO LABS LIMITED ($2.3M), EUGIA PHARMA SPECIALITIES LIMITED ($1.9M). Macleods Pharmaceuticals Ltd processed 27 shipments to 14 destination countries.
What Moxifloxacin Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES MOXIFLOXACIN HYDROCHLORIDE TABLETS400 mg | $237.7K | 11 |
| MOXIFLOXACIN 400MG TABS BNO:BMC32202A MF | $100.0K | 2 |
| MOXIMAC MOXIFLOXACIN HCL TABLETS 400MG B | $50.0K | 1 |
| MOXIFLOXACIN 400MG TABS. 10X10S 3650 | $50.0K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE 400MG TABS. | $50.0K | 1 |
| MOXIFLOXACIN 400 MG TABLETS. 10X10'S 6466 PACK | $50.0K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS. 10X10'S 6466 PACK | $50.0K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE 400MG TABLETS. (10X10'S) (2187 PACK) | $50.0K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE 400 MG TABLETS. (10X10'S) (6466 PACK) | $50.0K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE TABLETS 400 MG(12004 PACK,SIZE:10x10)(BATCH NO:14242850A,14242851A Mfg Dt:11/24 Exp Dt:10/29* | $50.0K | 1 |
Macleods Pharmaceuticals Ltd exports 33 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES MOXIFLOXACIN HY with 11 shipments worth $237.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Moxifloxacin to Key Markets
What Macleods Pharmaceuticals Ltd must comply with to export Moxifloxacin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Moxifloxacin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | EUGIA PHARMA SPECIALITIES LIMITED | $1.9M | 39 | 1 | $50.0K |
| 5 | AJANTA PHARMA LIMITED | $1.4M | 112 | 11 | $12.4K |
| 1 | MACLEODS PHARMACEUTICALS LTD ★ | $1.4M | 27 | 14 | $50.0K |
| 6 | MYLAN LABORATORIES LIMITED | $1.0M | 28 | 4 | $36.8K |
| 7 | AUROLAB TRUST | $806.3K | 192 | 46 | $4.2K |
Macleods Pharmaceuticals Ltd ranks #1 among 336 Indian Moxifloxacin exporters. Average shipment value of $50.0K compared to the market average of $42.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and AJANTA PHARMA LIMITED.
Which Indian Ports Ship Moxifloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 311 | 12.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 263 | 10.9% |
| DELHI AIR CARGO ACC (INDEL4) | 152 | 6.3% |
| DELHI AIR | 132 | 5.5% |
| NHAVA SHEVA SEA (INNSA1) | 126 | 5.2% |
| Bombay Air | 119 | 4.9% |
| CHENNAI AIR | 111 | 4.6% |
| CHENNAI AIR CARGO ACC (INMAA4) | 93 | 3.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 47 individual customs records matching Macleods Pharmaceuticals Ltd exporting Moxifloxacin, covering 33 formulations to 19 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Moxifloxacin Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Moxifloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Moxifloxacin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Moxifloxacin. For current shipment-level data, contact TransData Nexus.